Scientific Foundation
Our R&D framework is built on a Quality-by-Design (QbD) philosophy, combining molecular biology, biochemical engineering, and computational modeling. Early-stage design decisions are guided by predictive developability assessments to reduce downstream risk and improve manufacturability.
Core Capabilities
Cell Line & Expression Systems
valuation of expression constructs and host systems to achieve high-yield and stable production platforms for recombinant biologics.
- Vector & construct optimization
- Stable cell line development
- Productivity enhancement strategies
Upstream & Downstream Processing
End-to-end lab-scale process development ensuring scalability, reproducibility, and product quality.
- Bioreactor process optimization
- Harvest & purification strategies
- Process transfer readiness
Developability & Analytical Science
Integrated computational and experimental workflows to assess molecular stability and quality attributes.
- In silico developability screening
- Aggregation & stability prediction
- Analytical characterization & CQAs
R&D Pipeline
1. Discovery
Target selection, construct design, and early developability assessment.
2. Cell Line Development
Expression system optimization and stable clone selection.
3. Process Development
Upstream and downstream optimization at lab scale.
4. Characterization
Analytical profiling and biosimilarity assessment.